Temasek said to be weighing sale of Advanced MedTech at around $1b valuation

Temasek said to be weighing sale of Advanced MedTech at around $1b valuation

Photo: Bloomberg

Temasek Holdings is exploring selling Advanced MedTech, multiple sources told Reuters on Monday, after the medical devices firm, fully-owned by the Singaporean state investor, received interest from suitors including buyout funds.

Two investment banks have been tapped to launch a sale process for Singapore-headquartered MedTech, which could be valued at roughly $1 billion, two of the sources said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter